The expression of LXRα in most types of cancer cells is decreased (e.g., lung, breast, and kidney cancer cells), and its overexpression can suppress the EMT, metastasis, and proliferation of cancer cells; however, it can exert a contentious effect in some cancers, such as gastric cancer and liver cancer. This evidence concerns the gene NR1H3 and liver cancer.